Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial
Journal of Cancer Research and Clinical Oncology · 2026
DOI: 10.1007/s00432-026-06555-0 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2026. Verfasst von Chi Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Antineoplastic Combined Chemotherapy Protocols, Radiotherapy, Intensity-Modulated. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To prospectively explore efficacy and safety of radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer (CC).
Methods
Patients with locoregional recurrent CC were enrolled in the analysis. The enrolled patients received radiotherapy and albumin-bound paclitaxel and platinum-based chemotherapy. The primary endpoint was overall survival (OS). Secondary endpoints were progression-free survival (PFS), objective response rate (ORR), and safety.
Results
99 patients were enrolled. For all patients, the 3-year PFS and 3-year OS were 48.5% and 58.6%. 17.2% of patients achieved CR and 67.7% of patients achieved PR. The ORR was 84.8%. Moreover, 10.1% of patients were confirmed SD. The DCR was 94.9%.
Conclusion
Locoregional recurrent CC could benefit from radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
- Department of Digestive Endoscopic Center, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
- Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. wu.xh@fudan.edu.cn.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. wu.xh@fudan.edu.cn.
- Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. kegh5734@126.com.
Zitieren
APA
Fang, C., Liu, S., Xia, J., Wu, X., Ke, G., & Zhu, J. (2026). Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-026-06555-0
Vancouver
Fang C, Liu S, Xia J, Wu X, Ke G, Zhu J. Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial. Journal of Cancer Research and Clinical Oncology. 2026. doi:10.1007/s00432-026-06555-0
BibTeX
@article{Fang2026,
author = {Fang, Chi and Liu, Suping and Xia, Jie and Wu, Xiaohua and Ke, Guihao and Zhu, Jun},
title = {Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2026},
doi = {10.1007/s00432-026-06555-0}
}
EUVIMED